entertainment -WSS

entertainment

author：Wikipedia 2025-08-11 11:44:05 - browse：991

Scientist walks up a strand of DNA -- First Opinion coverage from STAT — Adobe

Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused on treatments for heart disease.

The deal, which also includes future milestone payments, is evidence that despite the pressure on biotechnology stocks there is still interest in very early cutting-edge technologies among big pharmaceutical players. It also provides Beam, which announced on Oct. 19 that it would cut 100 jobs, or 20% of its workforce, to save cash, a large infusion of money.

“This is like a true win-win-win deal, which is rare in this business, but it’s really, really exciting to see,” said John Evans, Beam’s CEO, in an interview with STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Wildfire pollution widens asthma inequities on Long Island

Wikipedia

WSS

How to bring more disabled researchers into academia

Amylyx ALS drug fails large clinical trial

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Headspace, Meta partner to launch VR meditation app for Quest

Mitch McConnell episode has important public health takeaway

What to expect as Trump is arraigned on his Jan 6. indictment

hotspot

entertainment

focus

Jerome Adams on the need for new antivirals for Covid

UnitedHealth quietly bought dozens of outpatient centers

How to save PrEP access — and even expand it

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Medicare details structure of new drug price negotiation program

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Trump demands the U.S. pay no more for drugs than other countries … again

Change Healthcare cyberattack prompts Medicare loan program

Hepatitis C has a cure — but many Americans still lack access to it

National panel will explore requiring free Covid tests

focus

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Change Healthcare cyberattack prompts Medicare loan program

Novo Nordisk obesity pill bests Wegovy in early trial

Just how do doctors, lawmakers, and the public define abortion?

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Amylyx ALS drug fails large clinical trial

Wikipedia

hotspot

hotspot

knowledge